Another suggamadex rejection

Discussion in 'Merck' started by Anonymous, Mar 14, 2015 at 10:08 AM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    FDA rejects it for the third time. How sweet it is! Karma...Yep!
     

  2. Anonymous

    Anonymous Guest

    A dumb idea from its inception. A dumb idea poorly implemented, no less. This is Merck, after all.

    That Kenny Boy sure does earn his $500 million per year, doesn't he? We couldn't possibly pay some honest, decent person $500K to run run this company into the ground, could we? No, we need to overpay Kenny Boy and his team of incompetent misfits.

    We could hire any one of our newest contract employees to do every bit the job that our CEO does. That's a true and sobering thought.
     
  3. Anonymous

    Anonymous Guest

    . Very true!

    My thought is to ditch Kenny and use his salary and those of his posse to buy some damn research talent back. Then again, the research talent is laughing in Merck's face.
     
  4. Anonymous

    Anonymous Guest

    Why is this drug having issues? Isn't is research clinical operations responsible for bringing this to market? It looks like the clinical trials are not being run correctly
     
  5. Anonymous

    Anonymous Guest

    Just read the message...fda says they are planning more inspections, as if they haven't inspected the hell out of the program already and could not have done this earlier.
    Lame excuses in order to delay and or annoy.
     
  6. Anonymous

    Anonymous Guest

    Suprised?
     
  7. Anonymous

    Anonymous Guest

    Surprised?
     
  8. Anonymous

    Anonymous Guest

    You get what you pay for when you outsource this's stuff.
     
  9. Anonymous

    Anonymous Guest

    Another 5 star Schering product, ha. Freddy boy is having a good laugh and some caviar on Merck! He's the ultimate salesman. Selling shit to a septic tank cleaner.